Synlogic

SYBX NASDAQ
7.06
-0.13
-1.81%
After Hours: 7.06 0 0.00% 17:04 07/19 EDT
Open
7.19
Prev Close
7.19
High
7.35
Low
6.90
Volume
170.57K
Avg Vol (3M)
141.10K
52 Week High
14.59
52 Week Low
5.75
% Turnover
0.67%
Market Cap
179.24M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Synlogic SYBX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Synlogic, Inc., formerly Mirna Therapeutics, Inc., is engaged in the development of a novel class of living treatments, Synthetic Biotic medicines. The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). It is also focused on Synthetic Biotic medicines to address other conditions, including inflammatory bowel disease , cancer and metabolic conditions, such as diabetes and obesity. The Company’s synthetic biotic medicines leverages the tools and principles of synthetic biology to genetically reengineer probiotic microbes to perform or deliver critical functions missing or damaged due to disease. The Company’s pipeline includes synthetic biotic medicines for the treatment of inborn errors of metabolism (IEM). It is developing SYNB1020 for the treatment of UCD and HE. It is developing SYNB1618 for the treatment of PKU.
MORE >

Recently

Name
Price
%Change